Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$102.31 +2.5%	$93.70	$77.10 ▼ $163.71	$5.85B	0.8	732,170 shs	1.05 million shs
GNMK GenMark Diagnostics	$24.04	$24.02	$8.42 ▼ $24.25	$1.76B	3.02	2.70 million shs	N/A
MMSI Merit Medical Systems	$92.95 +0.1%	$94.53	$80.84 ▼ $111.45	$5.49B	0.66	532,457 shs	336,019 shs
TFX Teleflex	$117.73 +0.2%	$125.67	$117.04 ▼ $249.91	$5.20B	1.1	628,032 shs	556,011 shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	0.00%	+5.10%	+4.94%	+0.28%	-9.77%
GNMK GenMark Diagnostics	0.00%	0.00%	0.00%	0.00%	0.00%
MMSI Merit Medical Systems	0.00%	-0.66%	-5.93%	-8.59%	+14.27%
TFX Teleflex	0.00%	-3.42%	-7.07%	-16.96%	-41.75%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GKOS Glaukos	4.5179 of 5 stars	4.4	2.0	0.0	4.4	2.3	2.5	0.6
GNMK GenMark Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	4.104 of 5 stars	3.5	1.0	0.0	3.8	2.1	2.5	1.3
TFX Teleflex	4.6099 of 5 stars	3.0	4.0	2.5	3.9	2.7	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GKOS Glaukos	2.75	Moderate Buy	$134.67	31.63% Upside
GNMK GenMark Diagnostics	0.00	N/A	N/A	N/A
MMSI Merit Medical Systems	3.00	Buy	$109.11	17.39% Upside
TFX Teleflex	2.09	Hold	$164.63	39.84% Upside

Current Analyst Ratings Breakdown

Latest GNMK, MMSI, TFX, and GKOS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00
5/21/2025	MMSI Merit Medical Systems	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$108.00 ➝ $112.00
5/21/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $108.00
5/15/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$100.00 ➝ $108.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00
5/5/2025	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$140.00 ➝ $137.00
5/5/2025	TFX Teleflex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$191.00 ➝ $173.00
5/2/2025	GKOS Glaukos	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$140.00 ➝ $115.00
5/2/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$150.00 ➝ $145.00
5/2/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$146.00 ➝ $137.00
5/1/2025	GKOS Glaukos	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$140.00 ➝ $135.00

(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GKOS Glaukos	$383.48M	15.24	N/A	N/A	$13.91 per share	7.35
GNMK GenMark Diagnostics	$88.02M	19.96	N/A	N/A	$0.21 per share	114.48
MMSI Merit Medical Systems	$1.36B	4.05	$5.61 per share	16.58	$23.67 per share	3.93
TFX Teleflex	$3.01B	1.73	$25.37 per share	4.64	$92.11 per share	1.28

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
GNMK GenMark Diagnostics	-$47.35M	-$0.82	N/A	N/A	N/A	-16.95%	-39.36%	-13.02%	N/A
MMSI Merit Medical Systems	$120.36M	$2.04	45.56	24.79	3.06	8.81%	15.52%	8.72%	7/30/2025 (Estimated)
TFX Teleflex	$69.68M	$3.17	37.14	7.76	1.84	4.96%	14.73%	8.79%	7/30/2025 (Estimated)

Latest GNMK, MMSI, TFX, and GKOS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
GNMK GenMark Diagnostics	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.16%	N/A	42.90%	N/A

Latest GNMK, MMSI, TFX, and GKOS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GKOS Glaukos	0.09	6.49	5.62
GNMK GenMark Diagnostics	0.75	4.33	3.84
MMSI Merit Medical Systems	0.51	4.87	3.26
TFX Teleflex	0.44	2.28	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GKOS Glaukos	99.04%
GNMK GenMark Diagnostics	96.94%
MMSI Merit Medical Systems	99.66%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
GKOS Glaukos	5.80%
GNMK GenMark Diagnostics	3.25%
MMSI Merit Medical Systems	3.20%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
GNMK GenMark Diagnostics	618	73.09 million	N/A	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	57.21 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

GNMK, MMSI, TFX, and GKOS Headlines

Recent News About These Companies

Boston Trust Walden Corp Has $18.15 Million Stake in Teleflex Incorporated (NYSE:TFX)

June 20 at 5:02 AM | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Analysts

June 18 at 2:06 AM | marketbeat.com

Teleflex (NYSE:TFX) Sets New 12-Month Low - Time to Sell?

June 17 at 6:10 PM | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Sold by Assenagon Asset Management S.A.

June 17 at 3:35 AM | marketbeat.com

SG Americas Securities LLC Takes $1.37 Million Position in Teleflex Incorporated (NYSE:TFX)

June 17 at 3:26 AM | marketbeat.com

Mountain Pacific Investment Advisers LLC Reduces Stock Position in Teleflex Incorporated (NYSE:TFX)

June 16, 2025 | marketbeat.com

Teleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCs

June 15, 2025 | msn.com

Yousif Capital Management LLC Increases Stock Position in Teleflex Incorporated (NYSE:TFX)

June 15, 2025 | marketbeat.com

Teleflex has positive Arrow catheter data

June 13, 2025 | massdevice.com

Pallas Capital Advisors LLC Invests $430,000 in Teleflex Incorporated (NYSE:TFX)

June 13, 2025 | marketbeat.com

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

June 12, 2025 | finance.yahoo.com

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

June 12, 2025 | globenewswire.com

Teleflex Launches Prostate Monster Campaign and Mobile Education Tour to Raise Awareness of BPH and Prostate Health

June 11, 2025 | quiverquant.com

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

June 11, 2025 | globenewswire.com

Teleflex Incorporated (NYSE:TFX) Shares Acquired by Rhumbline Advisers

June 8, 2025 | marketbeat.com

GAMMA Investing LLC Has $11.94 Million Position in Teleflex Incorporated (NYSE:TFX)

June 7, 2025 | marketbeat.com

Teleflex (TFX) Fell on Spin-Off Announcements

June 6, 2025 | msn.com

Surgical Equipment & Consumables - Specialty Stocks Q1 In Review: Integra LifeSciences (NASDAQ:IART) Vs Peers

June 4, 2025 | msn.com

Teleflex (NYSE:TFX) Sets New 12-Month Low - Here's Why

June 3, 2025 | marketbeat.com

Wellington Management Group LLP Acquires 66,075 Shares of Teleflex Incorporated (NYSE:TFX)

June 1, 2025 | marketbeat.com

California State Teachers Retirement System Lowers Stock Holdings in Teleflex Incorporated (NYSE:TFX)

June 1, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GNMK, MMSI, TFX, and GKOS Company Descriptions

Glaukos NYSE:GKOS

$102.31 +2.50 (+2.50%)

Closing price 06/18/2025 03:59 PM Eastern

Extended Trading

$101.46 -0.85 (-0.83%)

As of 06/18/2025 07:49 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

GenMark Diagnostics NASDAQ:GNMK

GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the developing and commercializing molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company also offers Blood Culture Identification Gram-Positive and Negative panel, Blood Culture Identification Fungal Pathogen panel, and ePlex Gastrointestinal Pathogen Panel. In addition, it provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. Further, the company offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, thrombophilia risk test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test and eSensor SARS-CoV-2 Test. GenMark Diagnostics, Inc. sells its products through direct sales and technically specialized service organization in the United States, Europe, and internationally. The company was incorporated in 2010 and is headquartered in Carlsbad, California.

Merit Medical Systems NASDAQ:MMSI

$92.95 +0.05 (+0.05%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$92.95 0.00 (0.00%)

As of 06/18/2025 05:10 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Teleflex NYSE:TFX

$117.73 +0.20 (+0.17%)

Closing price 06/18/2025 03:59 PM Eastern

Extended Trading

$117.72 0.00 (0.00%)

As of 06/18/2025 04:04 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time